COVID-19 vaccines in elderly subjects: Considerations on efficacy and safety
<p>The SARS-CoV-2 pandemic dramatically involved elderly subjects, causing a very high number of deaths in this specific population, with a risk of mortality reaching 50% in subjects older than 80 years [1-3]. As a consequence, as the world prepares for a mass campaign to vaccinate as many peo...
Saved in:
Main Author: | Marco Bongiovanni (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2021-05-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Some COVID-19 relevant considerations in the elderly
by: Ana Esther Despaigne Biset, et al.
Published: (2023) -
Considerations for vaccinating children against COVID-19
by: Fiona Russell, et al.
Published: (2023) -
COVID-19 Vaccine Videos: Health Literacy Considerations
by: Iris Feinberg, et al.
Published: (2023) -
COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake
by: Kaushal Parimi, et al.
Published: (2022) -
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
by: Danielle Gilbert, et al.
Published: (2023)